Why IBM, AMGN, GOOGL, & GILD Have Little to Gain With Trump In Charge

GILD stock, AMGN stock, GOOGL stock, & IBM stock may not gain much from a reduction in the corporate tax rate, but not all are bad investments.

Posted in BNL Market Analytics, Members, Timely Analysis | Tagged , , , , , , , , , | Leave a comment

Celgene (CELG), Valeant (VRX), Acadia (ACAD), & Gilead Sciences (GILD) Outlook On Drug Pricing Concerns

How Donald Trump’s stance on drug prices will affect each of BNL Finance covered biotechs: CELG, VRX, ACAD, JAZZ, and GILD.

Posted in Healthcare & Biotech, Members, Stock Ratings, Timely Analysis | Tagged , , , , , , , , , | Leave a comment

Why Acadia Pharmaceuticals (ACAD) Will Get More Than $44 From Pfizer (PFE)

Why ACAD stock will be the next Medivation. Pfizer, Gilead, Teva, Bristol-Myers, Otsuka & AbbVie are all companies that would want Nuplazid & Acadia Pharma

Posted in Healthcare & Biotech, Members, Mergers & Acquisitions | Tagged , , , , , , , , | 1 Comment

10 Acquisition Predictions For 2017: VRX, GILD, AmEx, SPLK, WFM

Acquisition predictions for 2017 that include VRX, GILD, AmEx, SPLK, & WFM being bought, and Takeda, Pfizer, Apple, IBM, and Kroger spending big.

Posted in Members, Mergers & Acquisitions | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Weekend Blitz: Twitter (TWTR), Fitbit (FIT), ACAD & FNMA Stock

Must know news and stories related to Twitter (NYSE:TWTR), Fitbit Inc (NYSE:FIT), ACADIA Pharmaceuticals (NASDAQ:ACAD), and Fannie Mae or FNMA stock.

Posted in Members, Portfolio Strategy, Weekend Blitz | Tagged , , , , , , , , , | Leave a comment

10 Dividend Stocks You Must Own In 2017: GILD, AT&T, SBGL, PFE, BP

In part 1 of a 2-part series David examines his top dividend stocks for 2017, which include GILD, AT&T, SBGL, PFE, and BP.

Posted in David's Dividends, Members, Portfolio Strategy | Tagged , , , , , , , , | Leave a comment

Why Nuplazid Alzheimer’s Data Is Great for ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock Owners, & Acquirers

Some are criticizing Phase 2 Nuplazid data on ADP, but we believe the implications for ACAD stock are much greater than most realize.

Posted in Healthcare & Biotech, Members, Mergers & Acquisitions | Tagged , , , | Leave a comment